TSLA Stock Slides As Earnings Loom Amid Safety Scrutiny

Tesla Inc. stocks have been trading down by -3.8 percent after reports of slowing EV demand and expanding Chinese competition.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading TSLA

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways TSLA Traders Must Watch

Cox Automotive projected Tesla’s Q3 U.S. new-vehicle sales to slump 31% year over year, badly trailing legacy automakers in a market where total sales are stable to rising.
Wall Street expects TSLA to post Q3 adjusted EPS of $0.45 on $28.06B in revenue, setting a clear bar for after-hours earnings.
A Brussels road-safety test flagged Tesla Full Self-Driving for speeding, risky cyclist passes, and misread limits, with findings sent to Belgian and Dutch regulators ahead of an EU approval vote.
U.S. regulators opened a probe into Tesla’s driverless taxis over alleged speeding in active school zones, a headline that aligned with a TSLA drop of up to 7.3%.
Tesla is struggling to ramp its Optimus humanoid robot and faces a delayed EU FSD vote to at least December, coinciding with another TSLA slide.

Live Update At 09:17:30 EDT: On Thursday, October 22, 2026 Tesla Inc. stock [NASDAQ: TSLA] is trending down by -3.8%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

TSLA is heading into Q3 earnings with traders on edge. Consensus targets $0.45 in adjusted EPS and $28.06B in revenue, so that’s the line in the sand the market cares about right now. The backdrop is not friendly. Cox Automotive expects Tesla’s U.S. Q3 new-vehicle sales to drop 31% year over year, even as overall auto volumes hold up. That screams demand and affordability pressure.

On the chart, TSLA has bounced from the mid-$350s to close near $386.47 on 2026/10/21. That’s a strong short-term recovery, but it’s happening into a huge binary event. The multi-day tape shows higher lows and steady grinding highs — constructive, but fragile if earnings disappoint.

More Breaking News

Fundamentally, Tesla still throws off serious revenue, roughly $94.83B over the last year, with an 18.9% gross margin and positive operating cash flow of $4.70B last quarter. But free cash flow was negative $1.10B after heavy capex, which tells traders the growth engine is expensive to feed. A sky-high P/E near 354 and rich price-to-sales around 14.6 mean TSLA is priced for perfection. Any stumble on margins, volume, or guidance can reset the whole story in a hurry.

Why Traders Are Watching TSLA So Closely

TSLA is not just another car stock; it trades like a high-beta tech name strapped to a regulatory lightning rod. Over the past few weeks, the news flow has turned into a steady drip of pressure points that traders ignore at their own risk.

First, demand. Both Cox Automotive and peer commentary flag Tesla’s Q3 U.S. sales slump of roughly 31% year over year and a year-over-year decline in deliveries. That is not happening in a weak market. Overall U.S. auto sales are flat to up, which means TSLA is losing relative momentum. For active trading, that’s a big deal — it undercuts the “endless demand” narrative that usually props up dips.

Next, safety and regulation. A Brussels-based test by Johanna.be claims Tesla Full Self-Driving frequently sped, misread limits, and made unsafe passes around cyclists. Those findings went straight to Belgian and Dutch regulators before an October EU vote on FSD. At the same time, U.S. regulators opened an investigation into Tesla’s driverless taxis for allegedly speeding in active school zones. TSLA sold off as much as 7.3% around that headline alone.

This is classic headline-risk territory. Every new probe or critical report on TSLA’s autonomy stack can trigger fast, outsized moves as algos and discretionary traders hit the same exits. Add in delays to a key EU FSD approval decision and setbacks in scaling the Optimus humanoid robot, and the long-duration “software and robotics” premium around Tesla looks less guaranteed in the near term.

Put it together, and TSLA is walking into earnings with rich valuation, slowing volume, and regulatory clouds — a mix that rewards nimble trading and punishes blind conviction.

Conclusion

For short-term TSLA traders, the setup around this Q3 earnings print is clear: expectations are defined, the chart is extended off recent lows, and the news tape is leaning bearish. A clean beat on the $0.45 EPS and $28.06B revenue marks, plus stable commentary on demand, could squeeze shorts and push Tesla stock through recent resistance near the high-$380s. But any miss, cautious outlook, or fresh safety headline will give sellers all the ammo they need.

Longer term, Tesla’s numbers still show a financially solid company. Low leverage, strong interest coverage, and nearly $16.43B in cash give TSLA plenty of runway. The problem for traders is not survival; it’s valuation versus reality. When U.S. volumes are down 31% and deliveries slip, paying tech-style multiples for an automaker-plus-software story becomes harder to justify.

That’s why disciplined trading around TSLA matters more than ever. You do not need to predict the future of robots, FSD, or EV adoption. You need to react faster than the crowd when the data hits. As Tim Sykes loves to remind traders, “Patterns repeat, but you have to study harder than anyone else and cut losses ruthlessly when the market proves you wrong.” As Tim Bohen, lead trainer with StocksToTrade says, “I focus on momentum that’s visible right now. Speculation on future moves is outside my playbook.” For anyone trading TSLA into this earnings storm, that mindset is not optional — it’s survival.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!